product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-Caveolin-1 (Tyr14) Antibody
catalog :
3251S
quantity :
100 ul
price :
274 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human, mouse, rat, dog
application :
western blot, immunoprecipitation
citations: 2
Published Application/Species/DilutionReference
Salatino M, Beguelin W, Peters M, Carnevale R, Proietti C, Galigniana M, et al. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation. Oncogene. 2006;25:7723-39 pubmed
Lim E, Smart E, Toborek M, Hennig B. The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. Am J Physiol Heart Circ Physiol. 2007;293:H3340-7 pubmed
product information
SKU :
3251S
Product-Name :
Phospho-Caveolin-1 (Tyr14) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, R, Mk, (Dg)
Applications :
Western blot
Product-Category :
Cytoskeletal Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
23, 25
Host :
Rabbit
Target :
caveolin-1 (Tyr14) phosphate
Primary-Protein :
caveolin-1
Alt-Names :
BSCL3,CAV,CAV1,CGL3,Caveolin-1,MSTP085,VIP21,caveolin 1, caveolae protein, 22kDa,cell growth-inhibiting protein 32
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.